EMA AI Tool Qualification: How the AIM-NASH App...

By Rene Pretorius

May 19, 2025

The European Medicines Agency (EMA) has issued its first Qualification Opinion (QO) for an
VIETNARMS Trial Unveils Innovative Hepatitis C Treatment Options
First At-Home HPV Testing Approval: FDA Clears Teal Wand
MR-107A-02: Revolutionizing Non-Opioid Pain Management with Viatris’ Breakthr...
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control
HCV Treatment Advancements: Atea Pharmaceuticals KOL Panel
TAVR Asymptomatic Approval: A New Era for Early Intervention in Aortic Stenosis
Ivonescimab NMPA Approval Signals Breakthrough in Lung Cancer
ZEVASKYN Gene Therapy: A Breakthrough for Recessive Dystrophic Epidermolysis ...
Nipocalimab for Myasthenia Gravis Treatment
Trodelvy Keytruda Combination Delivers Breakthrough Results in Metastatic Tri...
Urgent Need for Pediatric Heart Devices
FDA Approves Perioperative Immunotherapy for Bladder Cancer: A Breakthrough i...